Literature DB >> 1397874

Scintigraphic demonstration of lactulose-induced accelerated proximal colon transit.

L Barrow1, K P Steed, R C Spiller, P J Watts, C D Melia, M C Davies, C G Wilson.   

Abstract

Although lactulose, a widely used cathartic, is known to increase stool frequency, details of its site of action in the colon are obscure. In the present study a noninvasive scintigraphic technique was used to closely follow the movements of proximal colonic contents. Lactulose, 10-20 mL three times daily, significantly accelerated mean transit through the ascending colon from 12.9 +/- 3.7 to 7.0 +/- 2.5 hours (n = 11; P less than 0.01). This was associated with the occurrence of mass movements, with six such events seen during lactulose treatment whereas only one was seen during the control study (P less than 0.05). Lactulose also accelerated movement through the rest of the colon so that at 24 hours after dosing the geometric center of the isotope bolus was distal to that seen during the control study (6.6 +/- 1.2 vs. 4.7 +/- 1.3; n = 11, P less than 0.001). This model of diarrhea in otherwise normal subjects was subsequently used to study the effects of viscous gels in diarrhea. The viscous and relatively poorly fermented gel ispaghula, 3.5 g three times daily, abolished mass movements and was associated with a small but significant increase in proximal colonic transit time, which increased from 6.1 +/- 2.1 to 7.7 +/- 1.5 hours (n = 8; P less than 0.05). By contrast, the viscous but readily fermentable gelling agent guar gum, 5 g three times daily, further accelerated the cathartic effect of lactulose, with the mean transit time decreasing from 6.4 +/- 2.3 to 4.7 +/- 1.7 hours (n = 8; P less than 0.05). The acceleration of proximal colonic transit by lactulose may be a useful model to study diarrhea and its modification by therapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1397874     DOI: 10.1016/0016-5085(92)91500-4

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  11 in total

1.  Regional differences in quinine absorption from the undisturbed human colon assessed using a timed release delivery system.

Authors:  J M Hebden; C G Wilson; R C Spiller; P J Gilchrist; E Blackshaw; M E Frier; A C Perkins
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

2.  Slow-transit Constipation.

Authors:  Adil E. Bharucha; Sidney F. Philips
Journal:  Curr Treat Options Gastroenterol       Date:  2001-08

3.  Proximal colonic response and gastrointestinal transit after high and low fat meals.

Authors:  K P Steed; E K Bohemen; G M Lamont; D F Evans; C G Wilson; R C Spiller
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

4.  Quantitative, noninvasive assessment of antidiarrheal actions of codeine using an experimental model of diarrhea in man.

Authors:  L Barrow; K P Steed; R C Spiller; N A Maskell; J K Brown; P J Watts; C D Melia; M C Davies; C G Wilson
Journal:  Dig Dis Sci       Date:  1993-06       Impact factor: 3.199

5.  Sugar intolerance: origin and mechanisms of symptoms?

Authors:  Pauline Jouët; Jean-Marc Sabaté; Benoit Coffin; Yoram Bouhnik; Marc Lémann; Raymond Jian; Jean-Claude Rambaud; Bernard Flourié
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

6.  The distal colon provides reserve storage capacity during colonic fluid overload.

Authors:  J Hammer; M Pruckmayer; H Bergmann; K Kletter; A Gangl
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

7.  Stool water content and colonic drug absorption: contrasting effects of lactulose and codeine.

Authors:  J M Hebden; P J Gilchrist; A C Perkins; C G Wilson; R C Spiller
Journal:  Pharm Res       Date:  1999-08       Impact factor: 4.200

8.  Treatment of Severe and Intractable Constipation.

Authors:  Adil E. Bharucha
Journal:  Curr Treat Options Gastroenterol       Date:  2004-08

Review 9.  Colonic transit studies: normal values for adults and children with comparison of radiological and scintigraphic methods.

Authors:  Bridget R Southwell; Melanie C C Clarke; Jonathan Sutcliffe; John M Hutson
Journal:  Pediatr Surg Int       Date:  2009-06-02       Impact factor: 1.827

10.  Short-term supplementation of celecoxib-shifted butyrate production on a simulated model of the gut microbial ecosystem and ameliorated in vitro inflammation.

Authors:  Emma Hernandez-Sanabria; Evelien Heiremans; Marta Calatayud Arroyo; Ruben Props; Laurent Leclercq; Jan Snoeys; Tom Van de Wiele
Journal:  NPJ Biofilms Microbiomes       Date:  2020-02-19       Impact factor: 7.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.